IP Library Granted Patent US 7,122,654
Granted Patent B2
US 7,122,654 · App. 10/274,953 · Granted Oct 17, 2006

Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,122,654
App. No.
10/274,953
Granted
Oct 17, 2006
Kind
B2
Abstract

VEGF-D, a new member of the PDGF family of growth factors, which among other things stimulates endothelial cell proliferation and angiogenesis and increases vascular permeability, as well as nucleotide sequences encoding it, methods for producing it, antibodies and other antagonists to it, transfected or transformed host cells for expressing it, pharmaceutical compositions containing it, and uses thereof in medical and diagnostic applications.

Claims (3)

1. An isolated nucleic acid molecule which:

encodes a polypeptide having the ability to stimulate vascular permeability or proliferation of endothelial cells, and

comprises the nucleic acid sequence of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7 or a polynucleotide which hybridizes to one of the foregoing sequences at 42° C. in 5×SSC, 20 mM NaPO 4 , pH 6.8, 50% formamide, and washing at 42° C. in 0.2×SSC and which encodes a polypeptide comprising amino acids 93 through 201 of SEQ ID NO:5 or SEQ ID NO:9.

Assignments (3)
CHANGE OF NAME Recorded Jan 3, 2013
From: VEGENICS LIMITED
To: VEGENICS PTY LTD
Reel/Frame 029565/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH; LICENTIA LTD.
To: VEGENICS LIMITED
Reel/Frame 020243/0259 →
MERGER AND CHANGE OF NAME Recorded Jan 10, 2007
From: HELSINKI UNIVERSITY LICENSING LTD.
To: LICENTIA LTD.
Reel/Frame 018757/0418 →